The Textbook of Pharmaceutical Medicine, Fifth Edition

Content: Chapter 1 Discovery of New Medicines (pages 1–86): Anand S DuttaChapter 2 Pharmaceutical Development (pages 87–110): Gavin HalbertChapter 3 Preclinical Safety Testing (pages 111–143): David J TweatsChapter 4 Exploratory Development (pages 144–175): John PosnerChapter 5 Clinical Pharmacokinetics (pages 176–197): Paul Rolan and Valeria MolnarChapter 6 Purpose and Design of Clinical Trials (pages 198–238): Roger A YatesChapter 7 Conduct of Clinical Trials: Good Clinical Practice (pages 239–274): Roger A YatesChapter 8 Medical Statistics (pages 275–309): Andrew P GrieveChapter 9 Development of Medicines: Full Development (pages 310–328): Alan G Davies and Peter D StonierChapter 10 The Medical Department (pages 330–339): Darrall L Higson and PD StonierChapter 11 Medical Marketing (pages 340–354): John H YoungChapter 12 Information and Promotion (pages 355–379): D Michael HumphreysChapter 13 The Supply of Unlicensed Medicines for Particular Patient Use (pages 380–389): Amanda Wearing and John O'GradyChapter 14 Legal and Ethical Issues Relating to Medicinal Products (pages 390–409): Christine H Bendall and Christopher JS HodgesChapter 15 The Safety of Medical Products (pages 410–453): A Peter Fletcher and Susan ShawChapter 16 History of Drug Regulation in the United Kingdom (pages 456–488): John P Griffin and Rashmi R ShahChapter 17 Regulation of Human Medicinal Products in the European Union (pages 489–534): Rashmi R Shah and John P GriffinChapter 18 European Regulation of Medical Devices (pages 535–551): Christopher JS HodgesChapter 19 Technical Requirements for Registration of Pharmaceuticals for Human Use: the ICH Process (pages 552–564): Dean WG HarronChapter 20 The Regulation of Drug Products by the United States Food and Drug Administration (pages 565–601): Peter Barton HuttChapter 21 The US FDA in the Drug Development, Evaluation and Approval Process (pages 602–613): Richard N Spivey, Judith K Jones, William Wardell and William VodraChapter 22 Past Evolution and Future Prospects of the Pharma Industry and its Regulation in the USA (pages 614–636): William Wardell, William Vodra, Judith K Jones and Richard N SpiveyChapter 23 Regulatory and Clinical Trial Systems in Japan (pages 637–651): Yuichi KuboChapter 24 The Regulation of Therapeutic Products in Australia (pages 652–684): Janice Hirshorn and Deborah MonkChapter 25 Economics of Healthcare (pages 686–701): Carole Bradley and Jane R GriffinChapter 26 Controls on NHS Medicines Prescribing and Expenditure in the UK (A Historical Perspective) with some International Comparisons (pages 702–719): John P Griffin and Jane R Griffin